Rukhmi Bhat, Sebastien Malinge, Alan S. Gamis, April D. Sorrell, Joanne M. Hilden, Elisabeth Paietta, Martin S. Tallman and John D. Crispino (2009) “Mutational analysis of candidate tumor associated genes in Acute Megakaryoblastic Leukemia”
Linda C. Stork, Yousif Matloub, Emmett Broxson, Mei La, Rochelle Yanofsky, Harland Sather, Ray Hutchinson , Nyla A. Heerema, April D. Sorrell, Margaret Masterson, Archie Bleyer, and Paul S. Gaynon (2009) “Oral 6-Mercaptopurine vs. Oral 6-Thioguanine and Veno-Occlusive Disease in Children with Standard Risk Acute Lymphoblastic Leukemia: Report of the Children’s Oncology Group CCG-1952 Clinical Trial”
Norton A, Fisher C, Liu H, Wen O, Mundschau G, Fuster JL, Hasle H, Zeller B, Webb DK, O’Marcaigh A, Sorrell A, Hilden J, Gamis A, Crispino JD, Vyas P. (2007) “Analysis of JAK3, JAK2, and C-MPL mutations in transient myeloproliferative disorder and myeloid leukemia of Down syndrome blasts in children with Down syndrome”. Blood 110(3):1077-9, Aug 1, 2007.
Matloub Y, Lindemulder S, Gaynon PS, Sather H, La M, Broxson E, Yanofsky R, Hutchinson R, Heerema NA, Nachman J, Blake M, Wells LM, Sorrell AD, Masterson M, Kelleher JF, Stork LC. (2006) “Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared to intrathecal methotrexate: results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic leukemia. A report from the Children's Oncology Group”. Blood. Apr 11, 2006 [Epub ahead of print].
Prasad, R.S., Michaels, L.A., Roychowdri, S, Craig, V., Sorrell, A., Schonfeld, S. (2006) “Combined venous sinus angioplasty and low dose thrombolytic therapy for treatment of hemorrhagic transverse sinus thrombosis in a pediatric patient”. Journal of Pediatric Hematology and Oncology 28: 196-199, 2006.
Mukta Sharma, Todd A. Alonzo, April Sorrell, Robert B. Gerbing, Joanne M. Hilden, Robert J. Arceci, Gita Massey, John J. Doyle, Lisa Bayer, John P. Perentesis, Julie Ross, Franklin O. Smith, Russell Brynes, Jerry Hussong, Lois Hathaway, and Alan Gamis (2006) “Uniform Approach Better Defines Natural History of Transient Myeloproliferative Disorder (TMD) in Down Syndrome (DS) Neonates: Outcomes from Children’ Oncology Group(COG)Study A2971” Blood (ASH Annual Meeting Abstracts) 108: 376, Nov 2006.
Lamb LS, Neuberg R, Welsh J, Best R, Stetler-Stevenson M, Sorrell A. (2005) “T-Cell Lymphoblastic Leukemia/Lymphoma Syndrome with Eosinophilia and Acute Myeloid Leukemia” Clinical Cytometry 65:37-41, 2005.
Stork LC, Sather H, Hutchinson R, Broxson EH, Matloub Y, Yanofsky R, Masterson M, Sorrell A, Wells L, La M, Blake M, Gaynon PS. (2002) “Comparison of Mercaptopurine with Thioguanine and IT Methotrexate with IT “Triples” in Children with Standard Risk (SR) ALL: Results of CCG-1952”. Blood 100(11): 36a, 2002 (presented at ASH meeting 12-02).
Stork LC, Broxson EH, Sather H, Gaynon P, Matloub YH, Yanofsky R, Sorrell A, Wells L, Masterson M, Hutchinson RJ, Blake M, Sokol RJ. (2002) “Oral 6-thioguanine causes late-onset splenomegaly and portal hypertension in a subset of children with ALL”. Gastroenterology 7-02 (presented at Digestive Diseases Week meeting, 5-02).
This is a partial list. Full publications list available upon request. Information on this page may be self-reported and is subject to change at any time. Last updated: 07/10.